Skip to main content
. 2021 Sep 3;11(3):587–597. doi: 10.3390/clinpract11030074

Table 3.

Univariable and multivariable Cox’s proportional hazard regression analysis.

Univariate Analysis Multivariate Analysis
Parameter HR 95%CI p-Value HR 95%CI p-Value
Gender M/F Ref. =F 2.55 0.60–10.79 0.2034
Age 1.03 0.97–1.07 0.2823
Concomitant diseases:
Arterial hypertension 1.32 0.49–3.51 0.5736
DM 0.98 0.43–2.23 0.9668
Stroke 14.07 6.34–31.22 <0.0001
Hypercholesterolemia 1.35 0.59–3.11 0.4752
PAD 3.9 1.77–8.60 0.0007
Surgical indication:
LM disease 0.85 0.39–1.85 0.6906
3 vessels disease 1.14 0.52–2.50 0.7314
2 vessels disease 1.74 0.80–3.81 0.1597
Echocardiographic results:
LV diameter (mm) 1.08 1.02–1.16 0.0191
LVEF (%) 0.88 0.85–0.91 <0.0001 0.92 0.87–0.95 <0.0001
Preoperative:
(mean ± SD)
WBC, ×109/L 0.92 0.77–1.09 0.3248
Neutrophils, ×109/L 0.94 0.75–1.19 0.6364
Lymphocyte, ×109/L 0.78 0.45–1.35 0.3734
Hb, mmol/L 0.98 0.62–1.52 0.9218
Plt, ×109/L 1 0.99 -1.01 0.7882
NLR 1.04 0.84–1.29 0.6986
Troponin, ng/mL 0.91 0.34–2.41 0.8498
Postoperative 1st day:
(mean ± SD)
WBC, ×109/L 1.05 1.01–1.08 0.0059 1.18 1.07–1.30 0.0006
Neutrophils, ×109/L 1.59 1.33–1.89 <0.0001 0.36 0.22–0.58 <0.0001
Lymphocyte, ×109/L 0.64 0.37–1.10 0.1047
Hb, mmol/L 1.14 0.61–2.15 0.6848
Plt, ×109/L 1.01 1.01–1.01 0.0065 1.01 1.01–1.01 0.0038
NLR 1.47 1.30–1.65 <0.0001 1.61 1.18–2.18 0.0022
Troponin, ng/mL 0.99 0.99–1.01 0.8088
Postoperative 7th day:
(mean ± SD) 1.01 0.93–1.08 0.9178
WBC, ×109/L 1.11 0.93–1.32 0.2687
Neutrophils, ×109/L 0.99 0.87–1.12 0.8528
Lymphocyte, ×109/L 1.53 0.85–2.74 0.1524
Hb, mmol/L 0.98 0.99–1.01 0.3514
Plt, ×109/L 1.1 0.88–1.38 0.412
NLR 0.94 0.56–1.57 0.8105
Troponin, ng/mL

Abbreviations: F—female, DM—diabetes mellitus, Hb—hemoglobin, LV—left ventricle, LVEF—left ventricle ejection fraction, M—male NLR—neutrophil to lymphocyte ratio, PAD—peripheral artery disease, Plt—platelets.